Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

[6]-Shogaol/β-CDs inclusion complex: preparation, characterisation, in vivo pharmacokinetics, and in situ intestinal perfusion study.

Li R, Bao R, Yang QX, Wang QL, Adu-Frimpong M, Wei QY, Elmurat T, Ji H, Yu JN, Xu XM.

J Microencapsul. 2019 Aug;36(5):500-512. doi: 10.1080/02652048.2019.1649480. Epub 2019 Aug 14.

PMID:
31347417
2.

Inclusion complexes of HP-β-cyclodextrin with agomelatine: Preparation, characterization, mechanism study and in vivo evaluation.

Liao Y, Zhang X, Li C, Huang Y, Lei M, Yan M, Zhou Y, Zhao C.

Carbohydr Polym. 2016 Aug 20;147:415-425. doi: 10.1016/j.carbpol.2016.04.022. Epub 2016 Apr 8.

PMID:
27178948
3.

Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.

Zhao Y, Sun C, Shi F, Firempong CK, Yu J, Xu X, Zhang W.

Pharm Biol. 2016;54(1):130-8. doi: 10.3109/13880209.2015.1021816. Epub 2015 Apr 8.

PMID:
25853954
4.
5.

Intestinal Permeability of β-Lapachone and Its Cyclodextrin Complexes and Physical Mixtures.

Mangas-Sanjuan V, Gutiérrez-Nieto J, Echezarreta-López M, González-Álvarez I, González-Álvarez M, Casabó VG, Bermejo M, Landin M.

Eur J Drug Metab Pharmacokinet. 2016 Dec;41(6):795-806.

PMID:
26602766
6.

In vitro and in vivo effects of morin on the intestinal absorption and pharmacokinetics of olmesartan medoxomil solid dispersions.

Surampalli G, Satla M, Nanjwade BK, Patil PA.

Drug Dev Ind Pharm. 2017 May;43(5):812-829. doi: 10.1080/03639045.2016.1220569. Epub 2016 Aug 28.

PMID:
27487480
7.

Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.

Devasari N, Dora CP, Singh C, Paidi SR, Kumar V, Sobhia ME, Suresh S.

Carbohydr Polym. 2015 Dec 10;134:547-56. doi: 10.1016/j.carbpol.2015.08.012. Epub 2015 Aug 12.

PMID:
26428157
8.

Preparation, characterization and in vivo evaluation of a formulation of dantrolene sodium with hydroxypropyl-β-cyclodextrin.

Chen M, Wu Q, Jiang J, Jin X, Liu S, Wang M, Zhao C.

J Pharm Biomed Anal. 2017 Feb 20;135:153-159. doi: 10.1016/j.jpba.2016.12.022. Epub 2016 Dec 19.

PMID:
28027523
9.

Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.

Badr-Eldin SM, Elkheshen SA, Ghorab MM.

Eur J Pharm Biopharm. 2008 Nov;70(3):819-27. doi: 10.1016/j.ejpb.2008.06.024. Epub 2008 Jul 4.

PMID:
18655829
10.

Nanosuspensions Containing Oridonin/HP-β-Cyclodextrin Inclusion Complexes for Oral Bioavailability Enhancement via Improved Dissolution and Permeability.

Zhang X, Zhang T, Lan Y, Wu B, Shi Z.

AAPS PharmSciTech. 2016 Apr;17(2):400-8. doi: 10.1208/s12249-015-0363-4. Epub 2015 Jul 18.

11.

Curcumin-loaded solid lipid nanoparticles with Brij78 and TPGS improved in vivo oral bioavailability and in situ intestinal absorption of curcumin.

Ji H, Tang J, Li M, Ren J, Zheng N, Wu L.

Drug Deliv. 2016;23(2):459-70. doi: 10.3109/10717544.2014.918677. Epub 2014 Jun 3.

PMID:
24892628
12.

Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.

Nair AB, Attimarad M, Al-Dhubiab BE, Wadhwa J, Harsha S, Ahmed M.

Drug Deliv. 2014 Nov;21(7):540-7. doi: 10.3109/10717544.2013.853213. Epub 2013 Nov 12.

PMID:
24215288
13.

Effects of β-Cyclodextrin and Hydroxypropyl-β-Cyclodextrin Inclusions on the Degradation of Magnolol by Intestinal Bacteria.

Tang L, Zhu Z, Xie M, Cao L, Yu XL, Zhang R, Ou Z, Shan W, Zhang Z.

AAPS PharmSciTech. 2019 Jul 8;20(6):244. doi: 10.1208/s12249-019-1397-9.

PMID:
31286296
14.

[Pharmacokinetics and Intestinal Absorption of Curcumin Chitosan Hydrochloride Coated Liposome in Rats].

Wan SL, Zhong M, Yang M, Hu XY, Zhang JQ.

Zhong Yao Cai. 2015 Jan;38(1):132-5. Chinese.

PMID:
26214883
15.

Capsaicin pretreatment enhanced the bioavailability of fexofenadine in rats by P-glycoprotein modulation: in vitro, in situ and in vivo evaluation.

Bedada SK, Appani R, Boga PK.

Drug Dev Ind Pharm. 2017 Jun;43(6):932-938. doi: 10.1080/03639045.2017.1285310. Epub 2017 Feb 5.

PMID:
28102715
16.

Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.

Li N, Wang N, Wu T, Qiu C, Wang X, Jiang S, Zhang Z, Liu T, Wei C, Wang T.

Drug Dev Ind Pharm. 2018 Dec;44(12):1966-1974. doi: 10.1080/03639045.2018.1505904. Epub 2018 Sep 17.

PMID:
30059244
17.
18.

Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models.

Zhou W, Di LQ, Wang J, Shan JJ, Liu SJ, Ju WZ, Cai BC.

Acta Pharmacol Sin. 2012 Aug;33(8):1069-79. doi: 10.1038/aps.2012.58. Epub 2012 Jul 9.

19.

Enhanced aqueous solubility and bioavailability of capsaicin by the preparation of an inclusion complex.

Chen X, Sun X, Ren K, Zhang X, Zhang Z, Gong T.

Arzneimittelforschung. 2010;60(9):571-4. doi: 10.1055/s-0031-1296327.

PMID:
21117501
20.

Self-microemulsifying Drug Delivery System Improved Oral Bioavailability of 20(S)-Protopanaxadiol: From Preparation to Evaluation.

Wang B, Pu Y, Xu B, Tao J, Wang Y, Zhang T, Wu P.

Chem Pharm Bull (Tokyo). 2015;63(9):688-93. doi: 10.1248/cpb.c15-00247. Epub 2015 Jun 18.

Supplemental Content

Support Center